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Abstract
Background: Abnormal accumulation of neuronal intermediate filament (IF) is a pathological indicator of some
neurodegenerative disorders. However, the underlying neuropathological mechanisms of neuronal IF accumulation
remain unclear. A stable clone established from PC12 cells overexpressing a GFP-Peripherin fusion protein (pEGFP-
Peripherin) was constructed for determining the pathway involved in neurodegeneration by biochemical, cell
biology, and electronic microscopy approaches. In addition, pharmacological approaches to preventing neuronal
death were also examined.
Results: Results of this study showed that TUNEL positive reaction could be detected in pEGFP-Peripherin cells.
Swollen mitochondria and endoplasmic reticulum (ER) were seen by electron microscopy in pEGFP-Peripherin cells
on day 8 of nerve growth factor (NGF) treatment. Peripherin overexpression not only led to the formation of
neuronal IF aggregate but also causes aberrant neuronal IF phosphorylation and mislocation. Western blots
showed that calpain, caspase-12, caspase-9, and caspase-3 activity was upregulated. Furthermore, treatment with
calpain inhibitor significantly inhibited cell death.
Conclusions: These results suggested that the cytoplasmic neuronal IF aggregate caused by peripherin
overexpression may induce aberrant neuronal IF phosphorylation and mislocation subsequently trapped and
indirectly damaged mitochondria and ER. We suggested that the activation of calpain, caspase-12, caspase-9, and
caspase-3 were correlated to the dysfunction of the ER and mitochondria in our pEGFP-Peripherin cell model. The
present study suggested that pEGFP-Peripherin cell clones could be a neuronal death model for future studies in
neuronal IFs aggregate associated neurodegeneration.
Background
Peripherin is one of neuronal intermediate filament (IF)
proteins that predominantly expressed in the peripheral
nervous system (PNS) and in some neuronal populations
of the central nervous system (CNS) [1-3]. In developing
neurons, peripherin is abundant in the growth cones
and required for axonal outgrowth and maintenance
[4,5]. Together with other neuronal IFs, peripherin con-
stituted a shape-maintaining IF network in mature neu-
rons. It was reported that peripherin and a-internexin
can self-assemble or co-assemble with neurofilament
protein subunits to form the filamentous structure
before their translocation into the axons [6-11]. Neurofi-
lament triplet proteins are constructed by the neurofila-
ment light (NF-L, 61 kDa), medium (NF-M, 90 kDa)
and heavy (NF-H, 115kDa) subunits, all of which shared
the same central rod domain with peripherin [12,13].
Peripherin plays a crucial role in development of ner-
vous system and it can be highly relevant to pathogen-
esis of neurodegenerative disorder. In amyotrophic
lateral sclerosis (ALS) patients, peripherin together with
neuronal IFs were detected in the majority of abnormal
IF inclusion bodies in mature or aging motor neurons
[14-16]. Furthermore, an up-regulation of peripherin
mRNA was also found in a familial ALS case [17]. A
transgenic study showed that mice overexpressing per-
ipherin developed a late-onset motor neuron death and
IF inclusions resembling axonal spheroids found in ALS
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neurons microinjected with an expression vector coding
for the peripherin gene evoked an apoptotic cell death
[19]. Besides, a recent study indicated that overexpres-
sing peripherin can cause defective axonal transport of
type Ⅳ neurofilament proteins in cultured dorsal root
ganglion (DRG) neurons from peripherin transgenic
embryos [20]. These studies suggest that peripherin may
be an important etiological factor in neurodegenerative
diseases.
The PC12 cell line was derived from a rat pheochro-
mocytoma of adrenal medulla [21]. In response to nerve
growth factor (NGF) induction, PC12 cells differentiate
into a sympathetic neuron-like phenotype. This is char-
acterized by the display of a highly organized cytoskele-
ton, the synthesis of catecholamine neurotransmitters
and the acquisition of neurite [22]. It has been shown
that peripherin is highly expressed in the PC12 cells
[2,10]. Recent studies show that PC12 cells could be
applied as a good cellular model for studying the patho-
logical role of neuronal cytoskeletons in the neuronal
differentiation and cell death [22-24].
To gain a better understanding of the association
between overexpression of peripherin and neuronal cell
death, we examined the neurodegeneration via overex-
pression of peripherin in PC12 cells in this study. Bio-
chemical, cell biology, electronic microscopy, and
pharmacological approaches were applied to elucidate
the neuropathological mechanisms of neuronal IF
accumulation.
Methods
Cloning of the pEGFP-Peripherin construct
A 1.7 kb rat peripherin cDNA was cloned into the
HindⅢ site of pEGFP-C1 vector (Clontech, Palo Alto,
CA) to obtain the in-frame coding sequence with EGFP.
The junction for pEGFP-Peripherin fusion protein was
confirmed by DNA sequencing. The final construct was
named pEGFP-Peripherin.
DNA transfection and selection
For the DNA transfection, 1 ×10
7 cells were suspended
in 0.8 ml DMEM with 35 μg of DNA prepared by a
Qiagen Plasmid Kit (Qiagen, Valencia, CA). Electropora-
tion was performed by an ECM 830 electroporator
(BTX, San Diego, CA) at 225 V for a duration of 20 ms.
After transfection, cells were then plated on poly-D-
lysine coated dishes. Twenty-four hours after plating,
G418 (300 μg/ml, Invitrogen) was added to the medium
for the selection of transfected cells. After 12-day selec-
tion with G418, surviving PC12 cell colonies with green
fluorescence were picked up under an inverted fluores-
c e n c em i c r o s c o p e( L e i c aD MI R B EH C ,W e t z l a r ,
Germany).
Cell culture and drug treatment
The rat pheochromocytoma PC12 cell line (ATCC CRL-
1721TM) was maintained as described previously [23].
Briefly, control PC12 cells and pEGFP-Peripherin cells, a
stable clone established from PC12 cells overexpressing
an GFP-Peripherin fusion protein [23], were cultured in
Dulbecco’s modified Eagle’s medium (DMEM)(Invitro-
gen, Carlsbad, CA) containing 7.5% fetal bovine serum
(FBS), 7.5% horse serum (Invitrogen), and 1 × antibio-
tic/antimycotic (Invitrogen) at 37°C in a 5% CO2 incuba-
tor. To induce differentiation, the cells were seeded at
an initial density of 7.2 × 10
5 cells per 60 mm dish and
allowed to adhere for 2 h, then were exposed to med-
ium containing 100 ng/ml of nerve growth factor (NGF)
(R&D Systems Minneapolis, MN). The medium was
replaced with fresh medium containing NGF every 2
days.
When used, the selective calpain inhibitor calpeptin
(20 μM) (Calbiochem, La Jolla, CA), the caspase-9 inhi-
bitor Ac-LEHD-CMK (20 μM) (Calbiochem), the cas-
pase-12 inhibitor Z-ATAD-FMK (2 μM) (MBL, Nagoya,
Japan) was added to the medium on day 6, with 1%
DMSO being used as the vehicle control.
Antibodies
The mouse monoclonal antibodies used were anti-a-
fodrin (a-fodrin is also called a-spectrin) and anti-per-
ipherin (Chemicon, Temecula, CA), anti-phospho-NF-H
(SMI-36) and anti-phospho-NF-M (RMO55) (Upstate,
Lake Placid, NY), and anti-NF-H (N52), NF-M (NN18),
or NF-L (NR4) (Sigma-Aldrich). The rabbit antibodies
against active form of caspase-12, caspase-9 and
cleaved-caspase3 were purchased from Cell Signaling
Technology (Cell Signaling,D a n v e r s ,M A ) .T h em o u s e
anti-b-actin monoclonal antibody used as the internal
control was purchased from Novus (Novus Biologicals,
Littleton, CO).
Western blot analysis
Cells were collected and resuspended in lysis buffer (10
m MT r i s ,p H7 . 5 ,1 0 0m MN a C l ,1m ME D T A ,1m M
E G T A ,1 %T r i t o nX - 1 0 0 ,1 0 %g l y c e r o l ,0 . 1 %S D S ,0 . 5 %
deoxycholate with a proteinase inhibitor cocktail) for 15
minutes on ice, then the lysates were centrifuged at
14,000 g for 20 minutes at 4°C and the supernatant col-
lected for soluble protein analysis, while the pellet was
resuspended in SDS-urea buffer (6 M urea, 5% SDS) to
extract insoluble proteins for NF protein analysis. The
protein concentrations were measured by the Bradford
protein assay (Bio-Rad, Mississaura, ON, Canada).
Lysates containing 20 μgo r4 0μg of protein were elec-
trophoresed on a 8% or 15% SDS polyacrylamide gel
and transferred to a polyvinylidene difluoride membrane
(Millipore, Bedford, MA), which was then incubated for
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fered saline (TBS). Proteins were detected by incubating
the membranes overnight at 4°C with primary antibodies
against a-fodrin, p-NF-H, NF-H, p-NF-M, NF-M (all at
1:1000); cleaved caspase-3, caspase-9, caspase-12 (all at
1:500) and b-actin (1:5000) in 5% skim milk in TBS.
The blots were incubated for 1 h at room temperature
with horseradish peroxidase-conjugated goat anti-mouse
(AP124P) or goat anti-rabbit (AP132P) secondary anti-
bodies (Chemicon) at a dilution of 1:2000 in TBS with
5% skim milk. Western blotting luminal reagent kits
(PerkinElmer, Boston, MA) and BioMax films (Kodak,
Rochester, New York) were used for detection. The con-
trast and brightness of scanned gel pictures from Wes-
tern blot were slightly adjusted using Adobe Photoshop
CS3 extended 10.0 (Adobe Systems Incorporated, San
Jose, CA).
Immunocytochemistry
The cells were fixed in 4% paraformaldehyde for 15
minutes, washed 3 times in PBS, and covered with cold
100% methanol for 10 minutes. Primary antibodies were
applied overnight at 4°C, then the cells were rinsed for 5
× 3 minutes with PBS, followed by FITC-conjugated
goat anti-rabbit IgG and rhodamine-conjugated goat
anti-mouse IgG (Sigma-Aldrich) applied at a 1:200 dilu-
tion in PBS for 2 h at room temperature. The cell
nucleus was also labeled with fluorescent Hoechst 33342
(10 μg/mL, Sigma-Aldrich). After 5 more rinses in PBS,
the cells were mounted and viewed on a TCS SP5 con-
focal microscope (Leica).
Assessment of cell viability
The viability of pEGFP-Peripherin cells was determined
by the Trypan Blue dye exclusion assay [25]. After NGF
induction for 2, 4, 6, or 8 days, cells were collected in
an Eppendorf tube and washed twice in PBS, then
stained at room temperature for 5 minutes with 0.2%
Trypan Blue solution. The stained cells were counted on
a hemocytometer under a light microscope (Leica DM
IL). Cell viability was calculated as the percentage of
viable cells (not labelled with Trypan Blue) in the total
number of cells counted.
To evaluate the protective effects of protease inhibi-
tors on pEGFP-Peripherin cells, the XTT assay was
used. Briefly, after treatment with various inhibitors, cell
viability was evaluated by the ability of mitochondrial
succinate dehydrogenase in live cells to reduce XTT
(sodium 3’-1-(phenylaminocarbonyl)-3,4-tetrazolium-bis
(4-methoxy-6-nitro) benzene sulfonic acid) salt (Sigma-
Aldrich) to XTT formazan, measured on an ELx808
Absorbance Microplate Reader (Biotek InStruments,
Winooski, VT) at 490 nm with a reference correction at
630 nm.
Measurement of the mitochondrial membrane potential
(△Ψm)
The △Ψm was measured using the fluorescent dye, tetra-
methylrhodamine methyl ester (TMRE) (Invitrogen). At
the end of the various treatments, the culture medium
was removed and replaced by 50 nM TMRE in HEPES
buffer and the sampled were incubated for 20 minutes
at 37°C in a 5% CO2 incubator. Afterwards, the cells
were washed and Triton X-100 (final concentration =
0.2%) added to lyse the cells. The fluorescence of the
TMRE released from the mitochondria was measured by
fluorimetric analysis using a SPECTRAmax GEMINI XS
Microplate Spectrofluorometer (Molecular devices, Sun-
nyvale, CA) with excitation and emission wavelengths of
553 nm and 578 nm, respectively.
Transmission electron microscopy (TEM)
Cells were fixed for 2 h at 4°C with 4% glutaraldehyde in
0.1 M cacodylate buffer, pH 7.4, then rinsed 3 times in
0.1 M cacodylate buffer, post-fixed with 1% OsO4 in 0.1
M cacodylate buffer, dehydrated in a graded series of
ethanol (70%, 85%, 95%, and 100%), and embedded in
an Epon-araldite mixture. Ultrathin sections were pre-
pared, stained with uranyl acetate and lead citrate, and
examined on a Hitachi-7100 electron microscope (Hita-
chi, Tokyo, Japan) equipped with an AMT cooled CCD
camera (Advanced Microscopy Techniques, Danvers,
MA)..
Statistical analysis
The results are expressed as the mean ± SEM and were
evaluated for significance by un-paired Student’s t-test
for matched samples. Statistical significance was estab-
lished at a level of p < 0.05. Sigmaplot 8.0 (Systat Soft-
ware Inc., Chicago, IL) was used for data processing and
plotting histograms.
Results
Establishment of pEGFP-Peripherin stable cell lines
To examine the effect of exogenous peripherin on neu-
ronal IF structures and neuronal functions, the cDNA of
rat peripherin tagged with enhanced green fluorescence
protein (EGFP-Peripherin) was first transfected into
PC12 cells by electroporation. After G418 selection, 2
stable clones were established. In our previous study
[23], a stable PC12 clone expressing pEGFP was estab-
lished as a control group. There were no distinguishable
morphological differences between PC12 and pEGFP-
transfected PC12 cells and both cells extended short
neurites after NGF induction. Thus, EGFP overexpres-
sion in PC12 cells showed no effect on cell death and
neural differentiation [23]. The morphology of the stable
clone of pEGFP-Peripherin transfected PC12 cells under
the inverted fluorescence microscope is shown in Figure
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constantly and led to perikariyal aggregation in the
PC12 cells (Figure 1B). After NGF induction for 6 days,
transfected cells developed into neuronal phenotypes
including long neurites with green fluorescence.
Furthermore, protein aggregations composed of EGFP-
Peripherin were also found in the cytoplasm and some
cell processes (Figure 1C and 1D).
Overexpression of peripherin induces increased
expression of neuronal intermediate filaments and
neurofilament hyperphosphorylation in pEGFP-Peripherin
cells
Accumulation of phosphorylated neurofilament proteins
(p-NFs) in the cytoplasm or proximal axon is a hallmark
of many neurodegenerative diseases, such as Alzheimer’s
disease and amyotrophic lateral sclerosis [26-29]. To
examine whether overexpression of peripherin changed
the protein level of other neuronal intermediate fila-
ments, protein levels of nonphosphorylated and phos-
phorylated neurofilaments in PC12 cells and pEGFP-
Peripherin cells were assayed by Western blot (Figure
2). From our observations, the protein level of endogen-
ous peripherin was not changed between PC12 cells and
pEGFP-Peripherin cells. As we presumed, the ~80 kD
EGFP-Peripherin fusion protein was consistently
expressed in pEGFP-Peripherin stable clones. We found
that protein levels of nonphosphorylated and phos-
phorylated NF-H and NF-M were higher in pEGFP-Per-
ipherin cells than that observed in PC12 cells. However,
the protein level of NF-L was not significantly influ-
enced in pEGFP-Peripherin cells (Figure 2).
When the distribution of p-NFs in pEGFP-Peripherin
cells was examined immunocytochemically, p-NF-H and
p-NF-M were mainly observed in the neurites in control
PC12 cells, whereas in pEGFP-Peripherin cells, these
proteins were mainly found in the cytoplasm (Figure 3A
and 3B). These data show that overexpression of periph-
erin not only caused increased levels of neurofilaments,
but also resulted in abnormal perikaryal accumulation of
phosphorylated NFs in neurons.
Ultrastructural patterns of PC12 cells and pEGFP-
Peripherin cells
To examine if organelles were impaired in pEGFP-Per-
ipherin cells, we investigated the ultrastructure of PC12
cells and pEGFP-Peripherin cells after NGF treatment
for 8 days. Some mitochondria and dense core vesicles
Figure 1 A stable cell clone established from the PC12 cells
transfected with pEGFP-Peripherin. A pEGFP-Peripherin construct
was transfected into PC12 cells by electroporation. The stable clone
of transfected PC12 cells that persistently expressed the green
fluorescence protein could be detected (A and B). Some
accumulations of pEGFP- Peripherin proteins are found in the
cytoplasm and processes of transfected cells after NGF induction for
6 days (C and D). Aggregations of EGFP-Peripherin (arrows) in the
distal processes of the transfected cells could be observed (D). Scale
bar = 20 μm.
Figure 2 Western blot analysis of neurofilament proteins.
Protein levels of NF-H, phosphorylated NF-H, NF-M and
phosphorylated NF-M are enhanced in pEGFP-Peripherin cells,
especially at 8 days of NGF induction. However, protein level of NF-
L is not influenced in pEGFP-Peripherin cells. The EGFP-Peripherin
fusion protein is constantly expressed in pEGFP-Peripherin cells,
while not in PC12 cells. The protein level of endogenous peripherin
is similar between control PC12 cells and pEGFP-Peripherin cells.
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Page 4 of 12Figure 3 Cellular distribution of phosphorylated NFs in PC12 and pEGFP-Peripherin cells. (A and B) Distribution of phosphorylated NF
proteins in PC12 cells and pEGFP-Peripherin cells after NGF induction for 8 days examined by immunocytochemical staining with antibodies
against phosphorylated NF-H (p-NF-H) (A) or phosphorylated NF-M (p-NF-M) (B). p-NF-H and p-NF-M were detected in cytoplasmic aggregates
(arrows) in pEGFP-Peripherin cells. Scale bar = 20 μm.
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tiated PC12 cells on the 7th day of induction (Figure 4A
and 4B). Yet a few swelling mitochondria and randomly
distributed IFs could be found in the differentiated
pEGFP-Peripherin transfected cells (Figure 4C). Further-
more, several autophagosomes containing degraded
organelles such as mitochondria were seen in some of
differentiated neurons (Figure 4D). Abnormal IFs accu-
mulations were also found in the cytoplasm of the
pEGFP-Peripherin transfected cells after 7-day NGF
induction (Figure 4E). Apart from cytoplasm, several
electron-dense granules and a high density of IFs
together with membranous organelles including mito-
chondria and autophagosomes were also observed in the
Figure 4 Ultrastructural patterns of nontransfected PC12 cells and pEGFP-Peripehrin transfected cells after NGF induction for 7 days.
Ultrastructural patterns of nontransfected PC12 cells and pEGFP-Peripehrin transfected cells are examined on the 7th day of NGF induction.
Many dense core granules and typical mitochondria are found in the cytoplasm (A) and processes (B) of PC12 cells. Several swelling
mitochondria are observed in the cytoplasm of pEGFP-Peripherin transfected cells (C, arrow). Autophagosomes containing mitochondria are also
observed in the transfected cells (D, arrowhead). Abnormal IF accumulations are found in the cytoplasm (E) and processes (F) of pEGFP-
Peripherin transfected cells on the 7th day of NGF induction.
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these observations, we summarized that the overexpres-
sion of peripherin in the pEGFP-Peripherin transfected
cells caused excrescent IFs to accumulate in the cyto-
plasm and neurites. Moreover, the accumulation of IF
interferes with the normal functions of mitochondria
and rER, and subsequently induces other death events,
such as activation of the caspase cascade described
below.
Overexpression of peripherin in pEGFP-Peripherin cells
induces activation of calpain, caspase-12, caspase-9, and
caspase-3
On day 8 of NGF induction in our study, well-differen-
tiated neurons from PC12 cells were observed (Figure
5A-a), while a large amount of debris from degenerated
cells was seen in pEGFP-Peripherin cells (Figure 5A-b).
The viability of pEGFP-Peripherin cells decreased signif-
icantly compared to that of PC12 cells after NGF treat-
ment for 6 days (75.06 ± 1.42% versus 85.37 ± 0.83% n
=4 ;p < 0.001) or 8 days (66.19 ± 2.81% versus 82.9 ±
1.01%, n = 4; p < 0.01), as shown in Figure 5B.. Due to
the most neuronal cell death was through apoptosis
[30,31], we used TUNEL assay to further detect apopto-
sis of the control and pEGFP-Peripherin cells after NGF
induction. There were no detectable TUNEL positive
cells found in the cell aggregation of control PC12 cells
after 6 days of NGF inductio n( F i g u r e6 A ) .O n l yf e w
TUNEL positive cells were observed after 8 days NGF
induction in PC12 cells (Figure 6B). Some TUNEL posi-
tive cells could be found in pEGFP-Peripherin cells at 6
days of NGF induction (Figure 6C). An increased num-
ber of TUNEL positive cells was detected in pEGFP-Per-
ipherin cells after NGF induction for 8 days (Figure 6D).
We further investigated the activation of calpain and
caspase by Western blot analysis. Functional calpain
breaks down a-fodrin into a 145 kD cleavage product
(calpain breakdown product; calpain BDP) and the
detection of calpain BDP is performed in many studies
as an indication of calpain activation [32,33]. After NGF
induction for 8 days, calpain BDP levels in pEGFP-Per-
ipherin cells were higher (1.64 ± 0.19; n = 3; p < 0.05)
than those in PC12 cells (0.92 ± 0.08) (Figure 7A and
7B). Levels of active caspase-12 was also higher in
pEGFP-Peripherin cells than in PC12 cells after 4 days
(0.22 ± 0.02 versus 0.13 ± 0.01) of NGF induction (n =
3; p < 0.05) (Figure 7A and 7C), as were levels of active
caspase-9 on day 8 (0.93 ± 0.03 compared to 0.56 ±
Figure 5 Cell morphology and cell viability after NGF
induction. PC12 cells differentiate with neurite extension after NGF
induction for 8 days (A-a). Some cell debris (arrowheads) and
degenerating neurites are observed in pEGFP-Peripheirn cells after 8
days of NGF induction (A-b). (B) Cell viability assessed by Trypan
blue exclusion on different days of NGF induction. * *p < 0.01, *** p
< 0.001 in the t-test; n = 4. Scale bar = 20 μm.
Figure 6 TUNEL assays of PC12 and pEGFP-Peripherin cells
after NGF induction. TUNEL assay of control PC12 cells and
pEGFP-Peripherin cells at 6 and 8 days of NGF induction. Only few
TUNEL positive cells (arrows) could be found in the cell aggregation
of control PC12 cells at the 6 and 8 days of NGF induction (A and
B). (C) Some TUNEL positive cells could be found in pEGFP-
Peripherin cells at 6 days of NGF induction. (D) More TUNEL positive
cells could be detected in pEGFP-Peripherin cells after NGF
induction for 8 days. Scale bar = 20 μm.
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Page 7 of 12Figure 7 The activity of calpain, caspase-12, caspase-9, and caspase-3 is increased on 8 day of NGF induction in pEGFP-Peripherin
cells compared to PC cells. (A) Western blot analysis showing increased activation of caspase-12 (42 kD), caspase-9 (40 kD and 38 kD), and
caspase-3 (19 kD and 17 kD) on later stage of NGF induction in pEGFP-Peripherin cells compared to PC cells. (B-E) Density of the bands for the
calpain BDP (B), active caspase-12 (C), active caspase-9 (D), or active caspase-3 (E) relative to the b-actin band. The values are presented as the
mean ± SEM for three experiments in each group. *p < 0.05, **p < 0.01 vs. control PC12 cells.
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7D). Moreover, active caspase-3 was increased in
pEGFP-Peripherin cells compared to PC12 cells on day
4 (0.58 ± 0.04 versus 0.3 ± 0.02; n = 3; p <0 . 0 1 )o r6
(1.12 ± 0.09 versus 0.54 ± 0.12; n = 3; p <0 . 0 5 )o r8
(1.42 ± 0.08 versus 0.9 ± 0.15; n = 3; p < 0.05) days of
N G Fi n d u c t i o n( F i g u r e7 Aa n d7 E ) .T h ed a t as u g g e s t s
that activation of calpain, caspase 12, caspase 9 and cas-
pase-3 is involved in the neuronal death of pEGFP-Per-
ipherin cells. To elucidate the roles of calpain, caspase-
9, and caspase-12 in pEGFP-Peripherin cells, pEGFP-
Peripherin cells were treated with 20 μM Ac-LEHD-
CMK (caspase-9 inhibitor), 2 μM Z-ATAD-FMK (cas-
pase-12 inhibitor), or 20 μM calpeptin (a specific calpain
inhibitor) on day 6 for 48 hours [34]. Treatment with
calpeptin resulted in partial inhibition of caspase-3 acti-
vation where the production of the 120 kD fragment a-
fodrin produced by caspase-3 (caspase-3 BDP) decreased
(Figure 8A). Moreover, a significant inhibition of cell
death was observed (123.18 ± 3.26% of levels in
untreated cells; n = 8, p < 0.01) (Figure 8B). Calpeptin
also promoted neuronal functions, such as maintaining
the mitochondrial membrane potential (△Ψm) (113.85 ±
5.52% compared to untreated cells; n = 12, p < 0.05)
(Figure 8C). Casepase-9 and caspase-12 inhibitors did
not show significant effects on pEGFP-Peripherin cells.
These results show that caspase-3 activation in pEGFP-
Peripherin cells was blocked by a calpain inhibitor,
which also suppressed neuronal cell death in well-differ-
entiated pEGFP-Peripherin cells.
Discussion
Abnormal accumulation of neuronal IFs is a conspicu-
ous feature in many human neurodegenerative diseases
Figure 8 Effects of calpain, caspase-9, and caspase-12 inhibitors on the survival of pEGFP-Peripherin cells. pEGFP-Peripherin cells were
treated for 48 h with 20 μM calpeptin (calpain inhibitor), 20 μM Ac-LEHD-CMK (caspase-9 inhibitor), or 2 μM Z-ATAD-FMK (caspase-12 inhibitor)
starting on day 6 of NGF induction. (A) Proteins were analyzed by Western blotting. Caspase-3 activity was detected by levels of the 120 kD
caspase-3 breakdown product of a-fodrin (caspase-3 BDP). UT = untreated group. Equal loading of protein was confirmed using b-actin. (B) Cell
viability was evaluated using the XTT assay. The data are presented as the mean ± SEM for eight experiments in each group. **p < 0.01 versus
untreated group. (C) The mitochondria membrane potential was evaluated by the ability of the cells to take up the fluorescent dye TMRE. Data
are presented as the mean ± SEM for twelve experiments in each group. *p < 0.05 versus the untreated group.
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aggregates in the diseases are still unclear. We used the
pEGFP-Peripherin cell model to study possible neuro-
pathological pathways responsible for neurodegenerative
disorders. Neuronal IF aggregates were seen in the early
stages (d0-d2) of differentiation of pEGFP-Peripherin
cells, while neuronal death was significantly increased in
well-differentiated pEGFP-Peripherin cells (Figure 5).
Interestingly, hyperphosphorylation of NFs were also
observed in well-differentiated pEGFP-Peripherin cells
(Figure 2 and 3). NFs, especially NF-M and NF-H, have
many Lys-Ser-Pro (KSP) repeats in the C-terminal
region that can be phosphorylated by Cdk5 and GSK-3b
[39-48]. Phosphorylation of the C-terminal region, in
particular that of NF-H, regulates NF axonal transport
[49]. Extensive C-terminal NF phosphorylation-induced
impairment of NF axonal transport may be due to a
weak affinity for kinesin and premature NF-NF polymer-
ization [50-52]. In our case, immunofluorescence and
Western blot experiments have demonstrated that accu-
mulation of hyperphosphorylated neurofilaments in
cytoplasma of pEGFP-Peripherin cells (Figure 2 and 3).
These results lead us to an assumption that overexpres-
sion of peripherin may induce the accumulation of
hyperphosphorylated neurofilaments in cytoplasma that
resulted from inappropriate activation of kinases. There-
fore, we would like to further confirm which kinases
involved in neurofilament hyperphosphorylation in
pEGFP-Peripherin cells.
Transmission electron microscopy showed that not
only mitochondria, but also rER and autophagosomes,
were trapped in the neuronal IF aggregates in pEGFP-
Peripherin cells. Interestin g l y ,m a n ym i t o c h o n d r i aa n d
regions of rER were swollen, implying dysfunction of
t h e s eo r g a n e l l e s( F i g u r e4 C ,D ,Ea n d4 F ) .I th a sb e e n
reported that the ER and mitochondria can sense stress
and initiate the cell death pathway [53]. Active calpain,
caspase 12, caspase 9 and caspase-3 increased and were
detected in pEGFP-Peripherin cells (Figure 7). Calpain, a
cysteine protease, is mainly activated by elevated intra-
cellular calcium levels, and calpain activation is involved
in necrosis and apoptosis [54,55]. Calpain can activate
caspase-3, caspase-9, and caspase-12 [56-60]. Procas-
pase-12 can be activated by ER stress and mobilization
of intracellular calcium ion stores [60]. Caspase-9 is
involved in mitochondrial-induced apoptosis, and
cleaved caspase-9 activates caspase-3 to initiate the cas-
pase cascade, which leads to apoptosis [61]. In summary,
active caspase-12 sequentially activates caspase-9 and
caspase-3, resulting in induction of apoptosis [62]. Cas-
pase 12 and calpain might remain activated when treat-
ing with the caspase 9 inhibitor since calpain works
upstream of caspase in apoptosis [59,60] and activation
of caspase 9 requires caspase 12 [63]. In our
experiments, there is no significant change in the MMP
and cell viability after caspase 12 or 9 inhibitor treat-
ment. We supposed that single caspase inhibitor treat-
ment could not prevent cell death completely. When
treating with calpain inhibitor, cell death was dramati-
cally reduced in our study. Our functional analysis con-
firmed that caspase-3 activation was downregulated in
pEGFP-Peripherin cells by inhibitors of calpain, caspase-
12, or caspase-9 (Figure 8A). We suggest that activation
of calpain, caspase-12, caspase-9, and caspase-3 is impli-
cated in neuronal death of pEGFP-Peripherin cells.
Imbalance of cellular calcium ion could be caused by
ER and mitochondrial impairment and it might lead to
activations of calpain and caspases in apoptosis [64,65].
In our pEGFP-Peripherin cell model, we observed abun-
dant neuronal IF accumulation in the cytoplasm and
triggers hyperphosphorylation of NF proteins, which do
not transport to the axon and subsequently aggregate.
Mitochondria and ER are trapped in the neuronal IF
aggregates and indirectly damaged. We suggest that acti-
vation of calpain, caspase-12, caspase-9, and caspase-3
are correlated to the dysfunction of the ER and mito-
chondria in pEGFP-Peripherin cells.
Transgenic mice overexpressing wild-type mouse NF-
H or NF-M show neither muscle atrophy nor motor
neuron loss, despite prominent axonal swelling and peri-
karyal neurofilament accumulation in motor neurons
[66,67]. However, overexpression of peripherin devel-
oped a late-onset motor neuron death and IF inclusions
resembling axonal spheroids found in ALS patients [18].
Since neuronal IF accumulation is seen in the perikarya
and axons of affected motor neurons in SOD1 mutant
transgenic mice [68,69], this transgenic mouse model
will be a good candidate for confirming the therapeutic
effects of protein kinase inhibitors in vivo. Additionally,
both the ubiquitin-proteasome system and the autop-
hagy-lysosomal system are important in protein degra-
dation in neuronal metabolism [70].
Conclusions
In summary, these results suggested that the cytoplas-
mic neuronal IF aggregate caused by peripherin overex-
pression may induce aberrant neuronal IF
phosphorylation and mislocation subsequently trapped
and indirectly damaged mitochondria and ER. In our
pEGFP-Peripherin cell model, the dysfunction of the ER
and mitochondria is related to the activation of calpain,
caspase-12, caspase-9, and caspase-3. The present study
suggested that pEGFP-Peripherin cell clones could be a
neuronal death model for future studies in neuronal IFs
aggregate associated neurodegeneration. Furthermore,
our pEGFP-Peripherin cell model could provide a good
alternative system to the SOD1 mutant mice in vivo
model and can be used to study the protein degradation
Lee et al. Journal of Biomedical Science 2012, 19:8
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Page 10 of 12machinery and elucidate the complex neuropathological
underlying mechanisms of neuronal cell death.
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